D

하이퍼코퍼레이션

065650KOSDAQ기계장비 및 관련 물품 도매업

35.5 / 100

Reference Date: 2026-04-13

Financial Score7.0 / 40
News Sentiment12.5 / 25
Momentum9.0 / 20
Disclosure7.0 / 15
AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Declined 5.3% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Hyper Corporation operates three main business divisions: Commerce, Biopharma, and Tech. The Commerce division sells PC peripherals and household products, while the Biopharma division develops innovative drugs, including anti-inflammatory treatments, Alzheimer's therapies, and a non-opioid painkiller (MDR-652). The company is expanding its market through new ventures like the early dementia diagnostic kit QPLEX Alz Plus and the EcoVacs brand, driving revenue growth.

Number of Employees

83people

Average Salary

33.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 10.904.0Point
PBR
2.73Industry Average 0.770.0Point

3.5x industry avg (risky)

ROE
-4.61Industry Average 3.030.0Point

Well below industry avg

Debt Ratio
39.24Industry Average 6.160.0Point

6.4x industry avg (risky)

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲21.3% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼159.7% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -103.0% (improving, 3yr)

Detailed News Sentiment

5 totalPositive 1Neutral 0Negative 1Average Sentiment Score 50

Detailed Momentum

52-week position1.0Point

Near 52w low (5%, downtrend)

Current 1,912Won52-week high 6,09052-week low 1,654
1-month return2.0Point

1m -5.35% (slight drop)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

14 totalPositive 0Neutral 13Negative 1
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-01
  • Neutral대표이사변경2026-03-31
  • Neutral정기주주총회결과2026-03-31
  • Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-31
  • Neutral감사보고서제출2026-03-23